Ticagrelor Impurity 64 - Request Quote
Ticagrelor Impurity 64
| SZ CAT No: | SZ-T023146 |
| CAS No | NA |
| Mol.F. | C23H28F2N6O4S |
| Mol.Wt. | 522.6 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Ticagrelor Impurity 64 is chemically [1S-[1a,2a,3b(1S*,2R*)5b] ]-3-[7-(2-(3,4-difluorophenyl)cyclopropylamino)-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxy ethoxy)-cyclopentane-1,2 diol. Ticagrelor Impurity 64 is supplied with detailed characterization data compliant with regulatory guideline. Ticagrelor Impurity 64 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ticagrelor.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Ticagrelor Impurity 64
Purchase Ticagrelor Impurity 64
Ticagrelor Impurity 64 suppliers
Ticagrelor Impurity 64 manufacturers
Ticagrelor Impurity 64 price
Order Ticagrelor Impurity 64
Enquire Ticagrelor Impurity 64
Ticagrelor Impurity 64 cost
Ticagrelor Impurity 64 Supplier
Ticagrelor Impurity 64 Distributor
Ticagrelor Impurity 64 for Method Validation
Ticagrelor Reference Standard
Ticagrelor Impurity 64 for ANDA Filing
Ticagrelor Impurity 64 for Forced Degradation Studies
Ticagrelor Impurity 64 Identification Standards
Ticagrelor Impurity 64 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


